Replimune Group, Inc. - Common Stock — 현금 흐름 (NASDAQ:REPL) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

영업활동으로 인한 현금 -61.39 M-82.18 M-128.05 M-185.47 M-192.25 M -277.91 M 투자 활동으로 인한 현금 -188.78 M-1.81 M-142.5 M97.2 M-23.8 M 216.64 M 재무활동으로 인한 현금 372.46 M6.6 M311.3 M16.28 M252.4 M 10.48 M 잉여 현금 흐름 -63.78 M-84.52 M-130.32 M-191.13 M-198.94 M -283.27 M

뉴스

Biotech Investors Are Tuning Out the MAHA Chaos

What's Going On With Replimune Stock On Tuesday? - Replimune Group (NASDAQ:REPL)

Replimune stock collapses 64% following FDA rejection

Undercovered Stocks: Zscaler, Aeluma, Devon Energy, And More

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.63%

FDA Rejection Sparks Questions On Replimune Drug Approval Path - Replimune Group (NASDAQ:REPL)

Replimune Gets Second FDA CRL for Melanoma Drug BLA, Stock Crashes

Replimune: Second CRL May Have Sealed RP1's Fate - It's Hard To See Positives (REPL)

FDA Review Looms As Replimune Faces Weak Technical Setup - Replimune Group (NASDAQ:REPL)

Iovance Biotherapeutics: Positioned For Multi-Year Growth, Buy The Pullback (NASDAQ:IOVA)

RCKT Stock Down Despite FDA Nod to Gene Therapy in Rare Disease

CORT Rises on FDA Nod to Lifyorli in Platinum-Resistant Ovarian Cancer